heart failure glp-1 Receptor Agonists in GLP-1RA in Different HFpEF Phenotypes
Description
The metabolic benefits of GLP-1RAs are summarized in Table 3
BMJ Case Rep 14(1):e235663
The study was sponsored by Eli Lilly and Company, the manufacturer of orforglipron and the injectable GLP-1 tirzepatide
Focus on food quality and portion size to prevent nausea before it starts
However, patients continuing bDMARD therapy showed a lower LV mass index at follow-up compared with non-users, even after adjusting for inflammation, age, sex, and obesity
Can these drops really replace exercise or a balanced diet
